Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095706
Status:
COMPLETED
Last Update Posted:
2015-09-25
First Post:
2004-11-05
Brief Title:
Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab Antibodies Against HER2 and VEGF
Sponsor:
Organization:
Translational Oncology Research International